Cargando…
Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues
Despite the fact that COVID-19 vaccines are already available on the market, there have not been any effective FDA-approved drugs to treat this disease. There are several already known drugs that through drug repositioning have shown an inhibitory activity against SARS-CoV-2 RNA-dependent RNA polyme...
Autores principales: | Daikopoulou, Vasiliki, Apostolou, Panagiotis, Mourati, Sofia, Vlachou, Ioanna, Gougousi, Maria, Papasotiriou, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201013/ https://www.ncbi.nlm.nih.gov/pubmed/34200204 http://dx.doi.org/10.3390/molecules26113461 |
Ejemplares similares
-
Evaluation of Tegaran Formula ZhenHua cytotoxicity against human cancer cell lines
por: Parsonidis, Panagiotis, et al.
Publicado: (2020) -
Design, Synthesis, and In Vitro Activity of Pyrazine Compounds
por: Parsonidis, Panagiotis, et al.
Publicado: (2019) -
Genistein as a dietary supplement; formulation, analysis and pharmacokinetics study
por: Mamagkaki, Alexandra, et al.
Publicado: (2021) -
A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase
por: Khan, Suliman, et al.
Publicado: (2021) -
Potential Role for the Metnase Transposase Fusion Gene in Colon Cancer through the Regulation of Key Genes
por: Apostolou, Panagiotis, et al.
Publicado: (2014)